3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
9
Lymphoma, Large B-Cell, Diffuse
8
Lymphoma, Follicular
7
Rectal Neoplasms
6
Lymphoma, Mantle-Cell
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, B-Cell, Marginal Zone
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Hodgkin Disease
6
Congenital Abnormalities
6
Colonic Neoplasms
6
Burkitt Lymphoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myeloproliferative Disorders
5
Multiple Myeloma
5
Lymphoma, Non-Hodgkin
5
Leukemia, Myeloid, Acute
5
Sezary Syndrome
4
Mycosis Fungoides
4
Lymphoma, T-Cell, Cutaneous
4
Lymphoma
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Accelerated Phase
4
Leukemia
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Waldenstrom Macroglobulinemia
3
Recurrence
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Neuroblastoma
3
Interventions
Echocardiography
14
Doxorubicin
10
Exercise
8
Electrocardiography
7
Trastuzumab
6
Cyclophosphamide
5
Carvedilol
5
Docetaxel
3
Atorvastatin
3
salicylhydroxamic acid
2
sacubitril and valsartan sodium hydrate drug combination
2
empagliflozin
2
dapagliflozin
2
Tablets
2
Social Determinants of Health
2
Silymarin
2
Magnetic Resonance Spectroscopy
2
Ivabradine
2
High-Intensity Interval Training
2
Exercise Test
2
Chemoradiotherapy
2
Blood Specimen Collection
2
Bisoprolol
2
Antineoplastic Agents
2
Anthracyclines
2
sulforaphane
1
schizandrin
1
pegfilgrastim
1
nicotinamide-beta-riboside
1
mitoquinone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cardiotoxicity
×
Amplified Fragment Length Polymorphism Analysis
×
Clear all
NCT00875238
2018-02-19
PACE in BC
Vanderbilt University Medical Center
Completed
133 enrolled